Mandel S J, Larsen P R, Seely E W, Brent G A
Department of Medicine, Brigham and Women's Hospital, Boston, MA 02115.
N Engl J Med. 1990 Jul 12;323(2):91-6. doi: 10.1056/NEJM199007123230204.
Women with hypothyroidism have been thought not to require an increase in thyroxine replacement during pregnancy. To evaluate the effects of pregnancy on thyroxine requirements, we retrospectively reviewed the thyroid function of 12 women receiving treatment for primary hypothyroidism before, during, and after pregnancy.
In all patients, the serum thyrotropin level increased during pregnancy. The mean (+/- SE) serum free-thyroxine index decreased from 111.0 +/- 5.8 before pregnancy to 86.5 +/- 5.2 during pregnancy (normal, 64 to 142; P less than 0.05), and the mean serum thyrotropin level increased from 2.0 +/- 0.5 mU per liter before pregnancy to 13.5 +/- 3.3 mU per liter during pregnancy (normal, 0.5 to 5.0 mU per liter; P less than 0.01). Because of high thyrotropin levels, the thyroxine dose was increased in 9 of the 12 patients. Among the three patients who did not require an increased thyroxine dose were two with low serum thyrotropin levels before pregnancy, suggesting excessive replacement at that time. The mean thyroxine dose before pregnancy was 0.102 +/- 0.009 mg per day; it was increased to 0.148 +/- 0.015 mg per day during pregnancy (P less than 0.01). The mean postpartum serum free-thyroxine index was 136.6 +/- 11.4 (P less than 0.05 as compared with values before and during pregnancy), and the mean postpartum serum thyrotropin level was 1.4 +/- 0.4 mU per liter (P less than 0.01 as compared with levels during pregnancy), demonstrating a decrease in the thyroxine requirement. The mean postpartum thyroxine dose was decreased to 0.117 +/- 0.011 mg per day (P less than 0.01 as compared with the dose during pregnancy).
Our results indicate that the need for thyroxine increases in many women with primary hypothyroidism when they are pregnant, as reflected by an increase in serum thyrotropin concentrations. Although the effects of this modest level of hypothyroidism are not known, we think it prudent to monitor thyroid function throughout gestation and after delivery and to adjust the thyroxine dose to maintain a normal serum thyrotropin level.
以往认为甲状腺功能减退的女性在孕期无需增加甲状腺素替代治疗剂量。为评估妊娠对甲状腺素需求的影响,我们回顾性分析了12例接受原发性甲状腺功能减退治疗的女性在孕前、孕期及产后的甲状腺功能。
所有患者孕期血清促甲状腺素水平均升高。血清游离甲状腺素指数均值(±标准误)从孕前的111.0±5.8降至孕期的86.5±5.2(正常范围64至142;P<0.05),血清促甲状腺素均值从孕前的2.0±0.5 mU/L升至孕期的13.5±3.3 mU/L(正常范围0.5至5.0 mU/L;P<0.01)。由于促甲状腺素水平升高,12例患者中有9例增加了甲状腺素剂量。在3例无需增加甲状腺素剂量的患者中,有2例孕前血清促甲状腺素水平较低,提示当时替代治疗过度。孕前甲状腺素平均剂量为0.102±0.009 mg/天;孕期增至0.148±0.015 mg/天(P<0.01)。产后血清游离甲状腺素指数均值为136.6±11.4(与孕前及孕期值相比P<0.05),产后血清促甲状腺素均值为1.4±0.4 mU/L(与孕期水平相比P<0.01),表明甲状腺素需求减少。产后甲状腺素平均剂量降至0.117±0.011 mg/天(与孕期剂量相比P<0.01)。
我们的结果表明,许多原发性甲状腺功能减退的女性在孕期甲状腺素需求增加,这表现为血清促甲状腺素浓度升高。尽管这种轻度甲状腺功能减退的影响尚不清楚,但我们认为在整个孕期及产后监测甲状腺功能并调整甲状腺素剂量以维持血清促甲状腺素水平正常是谨慎的做法。